GlassScriptPhysician profile
Arcot S Premkumar
NPI 1265496665
$13,743.53
in general payments reported to CMS, 2019-2025
41 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,105 · 2020: $1,548 · 2021: $2,432 · 2022: $3,155 · 2023: $2,933 · 2024: $438 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,288 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,287.85 |
| Education | $215.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,766.33 | 2019-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $1,716.94 | 2019-2024 | Tezspire, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $1,436.06 | 2019-2024 | Trelegy Ellipta, Nucala, Shingrix |
| Insmed, INC. | $807.74 | 2019-2025 | Arikayce |
| Philips North America LLC | $803.80 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided, (7999) Src Undivided |
| Electromed, INC. | $701.02 | 2019-2024 | Smartvest |
| Genzyme Corporation | $682.50 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $669.97 | 2019-2024 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $668.17 | 2019-2023 | Opsumit, Uptravi |
| Genentech USA, INC. | $650.72 | 2019-2023 | Xolair |
| United Therapeutics Corporation | $628.29 | 2019-2024 | Tyvaso, Orenitram, Remodulin |
| Mylan Specialty L.P. | $346.14 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $319.36 | 2020-2024 | Glassia |
| Amgen INC. | $255.54 | 2021-2024 | Tezspire |
| Sunovion Pharmaceuticals INC. | $235.80 | 2019-2021 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $231.10 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $177.96 | 2019-2021 | |
| Grifols USA, LLC | $160.90 | 2019-2022 | |
| Sandoz INC. | $137.21 | 2019-2022 | |
| Allergan, INC. | $107.13 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $105.20 | 2021-2022 | |
| Intuitive Surgical, INC. | $99.24 | 2022 | |
| Abbvie INC. | $99.05 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $95.05 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $93.62 | 2019-2020 | |
| Shire North American Group INC | $86.09 | 2019 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2023 | |
| Paratek Pharmaceuticals, INC. | $73.27 | 2021-2022 | |
| Inogen, INC. | $63.89 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen One G3 Oxygen Concentrator |
| Merck Sharp & Dohme LLC | $61.03 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $59.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.09 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $55.79 | 2020-2021 | |
| Pulmonx Corporation | $44.67 | 2019-2021 | |
| Vapotherm INC | $36.56 | 2022 | |
| Gilead Sciences, INC. | $32.11 | 2019 | |
| Inspire Medical Systems, INC. | $26.23 | 2023 | Inspire |
| Cvrx, INC. | $22.57 | 2025 | Barostim Neo System |
| Novo Nordisk INC | $19.19 | 2025 | Wegovy |
| Abbott Laboratories | $17.37 | 2022 | |
| Circassia INC. | $15.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arcot Premkumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.